Details of the fifteenth meeting of the board of directors of the Egyptian Pharmaceutical Authority
& nbsp; Adawi, former Minister of Health and Population and Professor of Orthopedic Surgery, Dr. Hisham State, Chairman of the Board of Directors of the Egyptian Authority for Unified purchase, supply, medical supply and medical technology department, Dr. Ahmed Abdel Hamid Taha, Chairman of the General Authority for Accreditation and Health Supervision, Dr. Amani Osama Kamel, Vice President of Ain Shams University for Graduate Studies and Research, and Engineer Hani Abdel Qader El -Desouki, Executive Director of the National Council For accreditation. Where the total sales of the pharmaceutical market & nbsp; 309 billion pounds in 2024 compared to 216 billion pounds in 2023, which represents a growth rate of 43 % in the financial value. The authority won the reason for several credits at the international level during the last period, the most important of which is the accreditation of the Egyptian Drug Authority in the field of medicine and its obtaining the third level of maturity in the field of medicine by the World Health Organization in December 2024, after obtaining the third maturity level in the field of vaccines that it obtained in March 2022, and the authority’s laboratories from the World Health Organization and the European Union were approved; This is an important step to consider the commission’s laboratories as a global reference factor that depends on the analysis on the international level. The role, where he received a great responsibility for the authority to support African countries in this field, and the authority was also chosen as a regional training center by Auda-Nepad to become the continuous vocational development center in the authority a center for regional organizational excellence in Africa (RCORE), and as an extension of this pivotal role, 12 international training programs were presented to various Arab and African countries such as Libya, Yemen, Ghana And Algeria. Authority for Technical Development and Capacity Development Affairs and a member of the Board of Directors of the Authority, Dr. Amani Jawdat, Associate Chairman of the Authority for the Office of the Authority and Supervisor of the Central Administration of the Office of the Chairman of the Authority, Dr. Osama Hatem, Associate Chairman of the Authority for Policy and International Cooperation and the supervisor of the Central Administration for Pharmaceutical Policy and Markets Support, and Dr. Dalia Abu Hussein, Director of the General Administration for Quality Assurance.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
